KOD
Kodiak Sciences Inc
NASDAQ: KOD · HEALTHCARE · BIOTECHNOLOGY
$43.67
-3.87% today
Updated 2026-04-29
Market cap
$2.71B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-4.32
Dividend yield
—
52W range
$3 – $48
Volume
1.2M
WallStSmart proprietary scores
25
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C5.0
Quality
C+3.0
Profitability
D5.0
Valuation
C+—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →200 stocks currently score above 75
Price targets
Analyst target
$56.33
+28.99%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
1 Strong Buy5 Buy1 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
Insufficient data
Risks
- Thin margins at 0.00%
- Negative free cash flow $-39.42M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | $-333.82M | $-260.49M | $-176.21M | $-229.97M | $-56.74M |
| EPS | — | — | — | — | $-4.32 |
| Free cash flow | $-253.82M | $-195.61M | $-117.72M | $-136.51M | $-39.42M |
| Profit margin | — | — | — | — | — |
Peer comparison
Smart narrative
Kodiak Sciences Inc trades at $43.67. Our Smart Value Score of 25/100 indicates the stock is weak.
Frequently asked questions
What is Kodiak Sciences Inc's stock price?
Kodiak Sciences Inc (KOD) trades at $43.67.
Is Kodiak Sciences Inc overvalued?
Smart Value Score 25/100 (Grade F, Strong Sell).
What is the price target of Kodiak Sciences Inc (KOD)?
The analyst target price is $56.33, representing +29.0% upside from the current price of $43.67.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio—
ROE-149.50%
Beta2.40
50D MA$33.26
200D MA$21.34
Shares out0.06B
Float0.04B
Short ratio—
Avg volume1.2M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—